These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

618 related items for PubMed ID: 17057563

  • 1. A randomized, placebo-controlled study of fentanyl buccal tablet for breakthrough pain in opioid-treated patients with cancer.
    Portenoy RK, Taylor D, Messina J, Tremmel L.
    Clin J Pain; 2006; 22(9):805-11. PubMed ID: 17057563
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Fentanyl buccal tablet (FBT) for relief of breakthrough pain in opioid-treated patients with chronic low back pain: a randomized, placebo-controlled study.
    Portenoy RK, Messina J, Xie F, Peppin J.
    Curr Med Res Opin; 2007 Jan; 23(1):223-33. PubMed ID: 17207304
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Fentanyl buccal tablet for the treatment of breakthrough pain in opioid-tolerant patients with chronic cancer pain: A long-term, open-label safety study.
    Weinstein SM, Messina J, Xie F.
    Cancer; 2009 Jun 01; 115(11):2571-9. PubMed ID: 19373888
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A randomized, double-blind, placebo-controlled study of fentanyl buccal tablets for breakthrough pain: efficacy and safety in Japanese cancer patients.
    Kosugi T, Hamada S, Takigawa C, Shinozaki K, Kunikane H, Goto F, Tanda S, Shima Y, Yomiya K, Matoba M, Adachi I, Yoshimoto T, Eguchi K.
    J Pain Symptom Manage; 2014 Jun 01; 47(6):990-1000. PubMed ID: 24099893
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Consistent and clinically relevant effects with fentanyl buccal tablet in the treatment of patients receiving maintenance opioid therapy and experiencing cancer-related breakthrough pain.
    Zeppetella G, Messina J, Xie F, Slatkin NE.
    Pain Pract; 2010 Jun 01; 10(4):287-93. PubMed ID: 20230447
    [Abstract] [Full Text] [Related]

  • 11. Effect of fentanyl buccal tablet on pain-related anxiety: a 4-week open-label study among opioid-tolerant patients with chronic and breakthrough pain.
    Webster LR, Messina J, Xie F, Nalamachu S.
    J Opioid Manag; 2011 Jun 01; 7(4):297-308. PubMed ID: 21957829
    [Abstract] [Full Text] [Related]

  • 12. A randomized, placebo-controlled study of a new sublingual formulation of fentanyl citrate (fentanyl ethypharm) for breakthrough pain in opioid-treated patients with cancer.
    Novotna S, Valentova K, Fricova J, Richterova E, Harabisova S, Bullier F, Trinquet F, ETHYFYL Study Group.
    Clin Ther; 2014 Mar 01; 36(3):357-67. PubMed ID: 24508417
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Fentanyl buccal tablet: faster rescue analgesia for breakthrough pain?
    Lecybyl R, Hanna M.
    Future Oncol; 2007 Aug 01; 3(4):375-9. PubMed ID: 17661711
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Fentanyl buccal tablet compared with immediate-release oxycodone for the management of breakthrough pain in opioid-tolerant patients with chronic cancer and noncancer pain: a randomized, double-blind, crossover study followed by a 12-week open-label phase to evaluate patient outcomes.
    Webster LR, Slevin KA, Narayana A, Earl CQ, Yang R.
    Pain Med; 2013 Sep 01; 14(9):1332-45. PubMed ID: 23855816
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The efficacy and safety of fentanyl buccal tablet compared with immediate-release oxycodone for the management of breakthrough pain in opioid-tolerant patients with chronic pain.
    Ashburn MA, Slevin KA, Messina J, Xie F.
    Anesth Analg; 2011 Mar 01; 112(3):693-702. PubMed ID: 21304148
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Sublingual administration of fentanyl to cancer patients is an effective treatment for breakthrough pain: results from a randomized phase II study.
    Lennernäs B, Frank-Lissbrant I, Lennernäs H, Kälkner KM, Derrick R, Howell J.
    Palliat Med; 2010 Apr 01; 24(3):286-93. PubMed ID: 20015921
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.